FEATURED COMPANIES
- Anecova SA
- CRITEX GmbH
- Esco Micro Pte. Ltd
- FUJIFILM Holdings Corp.
- INVO Bioscience Inc
- Merck KGaA
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Global Assisted Reproductive Technology Market 2020-2024
The publisher has been monitoring the global assisted reproductive technology market 2020-2024 and it is poised to grow by USD 6.31 bn during 2020-2024, progressing at a CAGR of 4% during the forecast period. The report on the global assisted reproductive technology market 2020-2024 provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in rate of infertility and obesity related cases. In addition, increase in awareness of art is anticipated to boost the growth of the global assisted reproductive technology market 2020-2024 as well.
Market Segmentation
Global assisted reproductive technology market 2020-2024 is segmented as below:
Application:
This study identifies increase in awareness of art as the prime reasons driving the global assisted reproductive technology market 2020-2024 growth during the next few years.
Prominent vendors in global assisted reproductive technology market 2020-2024
The publisher provides a detailed analysis of around 25 vendors operating in the global assisted reproductive technology market 2020-2024, including some of the vendors such as Anecova SA, CRITEX GmbH, Esco Micro Pte. Ltd, FUJIFILM Holdings Corp., INVO Bioscience Inc, Merck KGaA, Monash IVF Group Ltd., The Cooper Companies Inc., Virtus Health Ltd. and Vitrolife AB .
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher has been monitoring the global assisted reproductive technology market 2020-2024 and it is poised to grow by USD 6.31 bn during 2020-2024, progressing at a CAGR of 4% during the forecast period. The report on the global assisted reproductive technology market 2020-2024 provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in rate of infertility and obesity related cases. In addition, increase in awareness of art is anticipated to boost the growth of the global assisted reproductive technology market 2020-2024 as well.
Market Segmentation
Global assisted reproductive technology market 2020-2024 is segmented as below:
Application:
- Fertility Clinics
- Hospitals
- Others
- APAC
- Europe
- MEA
- North America
- South America
This study identifies increase in awareness of art as the prime reasons driving the global assisted reproductive technology market 2020-2024 growth during the next few years.
Prominent vendors in global assisted reproductive technology market 2020-2024
The publisher provides a detailed analysis of around 25 vendors operating in the global assisted reproductive technology market 2020-2024, including some of the vendors such as Anecova SA, CRITEX GmbH, Esco Micro Pte. Ltd, FUJIFILM Holdings Corp., INVO Bioscience Inc, Merck KGaA, Monash IVF Group Ltd., The Cooper Companies Inc., Virtus Health Ltd. and Vitrolife AB .
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Anecova SA
- CRITEX GmbH
- Esco Micro Pte. Ltd
- FUJIFILM Holdings Corp.
- INVO Bioscience Inc
- Merck KGaA
Executive Summary
1. Key Finding 1
2. Key Finding 2
3. Key Finding 3
4. Key Finding 5
5. Key Finding 6
6. Key Finding 7
7. Key Finding 8
8. Market in focus
10. Parent market
13. Market characteristics
15. Offerings of vendors included in the market definition
17. Market segments
22. Global - Market size and forecast 2019 - 2024 ($ billion)
23. Global market: Year-over-year growth 2019 - 2024 (%)
24. Five forces analysis 2019 & 2024
27. Bargaining power of buyers
29. Bargaining power of suppliers
30. Threat of new entrants
31. Threat of substitutes
32. Threat of rivalry
34. Market condition - Five forces 2019
36. Application placement - Market share 2019-2024 (%)
37. Comparison by Application
40. Fertility clinics - Market size and forecast 2019-2024 ($ billion)
41. Fertility clinics - Year-over-year growth 2019-2024 (%)
44. Hospitals - Market size and forecast 2019-2024 ($ billion)
45. Hospitals - Year-over-year growth 2019-2024 (%)
48. Others - Market size and forecast 2019-2024 ($ billion)
49. Others - Year-over-year growth 2019-2024 (%)
51. Market opportunity by Application
52. Customer landscape
54. Market share by geography 2019-2024 (%)
55. Geographic comparison
58. Europe - Market size and forecast 2019-2024 ($ billion)
60. Europe - Year-over-year growth 2019-2024 (%)
63. North America - Market size and forecast 2019-2024 ($ billion)
65. North America - Year-over-year growth 2019-2024 (%)
68. APAC - Market size and forecast 2019-2024 ($ billion)
70. APAC - Year-over-year growth 2019-2024 (%)
73. South America - Market size and forecast 2019-2024 ($ billion)
75. South America - Year-over-year growth 2019-2024 (%)
78. MEA - Market size and forecast 2019-2024 ($ billion)
80. MEA - Year-over-year growth 2019-2024 (%)
82. Key leading countries
84. Market opportunity by geography ($ billion)
85. Impact of drivers and challenges
86. Vendor landscape
88. Landscape disruption
90. Industry risks
92. Vendors covered
94. Market positioning of vendors
96. Anecova SA - Overview
97. Anecova SA - Product and service
98. Anecova SA - Key offerings
99. Anecova SA - Key customers
100. Anecova SA - Segment focus
102. CRITEX GmbH - Overview
103. CRITEX GmbH - Product and service
104. CRITEX GmbH - Key offerings
105. CRITEX GmbH - Key customers
106. CRITEX GmbH - Segment focus
108. Esco Micro Pte. Ltd - Overview
109. Esco Micro Pte. Ltd - Product and service
110. Esco Micro Pte. Ltd - Key offerings
111. Esco Micro Pte. Ltd - Key customers
112. Esco Micro Pte. Ltd - Segment focus
114. FUJIFILM Holdings Corp. - Overview
115. FUJIFILM Holdings Corp. - Business segments
116. FUJIFILM Holdings Corp. - Key offerings
117. FUJIFILM Holdings Corp. - Key customers
118. FUJIFILM Holdings Corp. - Segment focus
120. INVO Bioscience Inc - Overview
121. INVO Bioscience Inc - Product and service
122. INVO Bioscience Inc - Key offerings
123. INVO Bioscience Inc - Key customers
124. INVO Bioscience Inc - Segment focus
126. Merck KGaA - Overview
127. Merck KGaA - Business segments
128. Merck KGaA - Key offerings
129. Merck KGaA - Key customers
130. Merck KGaA - Segment focus
132. Monash IVF Group Ltd. - Overview
133. Monash IVF Group Ltd. - Business segments
134. Monash IVF Group Ltd. - Key offerings
135. Monash IVF Group Ltd. - Key customers
136. Monash IVF Group Ltd. - Segment focus
138. The Cooper Companies Inc. - Overview
139. The Cooper Companies Inc. - Business segments
140. The Cooper Companies Inc. - Key offerings
141. The Cooper Companies Inc. - Key customers
142. The Cooper Companies Inc. - Segment focus
144. Virtus Health Ltd. - Overview
145. Virtus Health Ltd. - Business segments
146. Virtus Health Ltd. - Key offerings
147. Virtus Health Ltd. - Key customers
148. Virtus Health Ltd. - Segment focus
150. Vitrolife AB - Overview
151. Vitrolife AB - Business segments
152. Vitrolife AB - Key offerings
153. Vitrolife AB - Key customers
154. Vitrolife AB - Segment focus
156. Currency conversion rates for US$
157. Research Methodology
158. Validation techniques employed for market sizing
159. Information sources
160. List of abbreviations
- Market Overview
- Market ecosystem
- Value chain analysis
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 - 2024
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
- Market segments
- Comparison by Application
- Fertility clinics - Market size and forecast 2019-2024
- Hospitals - Market size and forecast 2019-2024
- Others - Market size and forecast 2019-2024
- Market opportunity by Application
- Overview
- Geographic segmentation
- Geographic comparison
- Europe - Market size and forecast 2019-2024
- North America - Market size and forecast 2019-2024
- APAC - Market size and forecast 2019-2024
- South America - Market size and forecast 2019-2024
- MEA - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
- Market drivers
- Volume driver - Demand led growth
- Volume driver - Supply led growth
- Volume driver - External factors
- Volume driver - Demand shift in adjacent markets
- Price driver - Inflation
- Price driver - Shift from lower to higher-priced units
- Market challenges
- Market trends
- Overview
- Landscape disruption
- Vendors covered
- Market positioning of vendors
- Anecova SA
- CRITEX GmbH
- Esco Micro Pte. Ltd
- FUJIFILM Holdings Corp.
- INVO Bioscience Inc
- Merck KGaA
- Monash IVF Group Ltd.
- The Cooper Companies Inc.
- Virtus Health Ltd.
- Vitrolife AB
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
1. Key Finding 1
2. Key Finding 2
3. Key Finding 3
4. Key Finding 5
5. Key Finding 6
6. Key Finding 7
7. Key Finding 8
8. Market in focus
10. Parent market
13. Market characteristics
15. Offerings of vendors included in the market definition
17. Market segments
22. Global - Market size and forecast 2019 - 2024 ($ billion)
23. Global market: Year-over-year growth 2019 - 2024 (%)
24. Five forces analysis 2019 & 2024
27. Bargaining power of buyers
29. Bargaining power of suppliers
30. Threat of new entrants
31. Threat of substitutes
32. Threat of rivalry
34. Market condition - Five forces 2019
36. Application placement - Market share 2019-2024 (%)
37. Comparison by Application
40. Fertility clinics - Market size and forecast 2019-2024 ($ billion)
41. Fertility clinics - Year-over-year growth 2019-2024 (%)
44. Hospitals - Market size and forecast 2019-2024 ($ billion)
45. Hospitals - Year-over-year growth 2019-2024 (%)
48. Others - Market size and forecast 2019-2024 ($ billion)
49. Others - Year-over-year growth 2019-2024 (%)
51. Market opportunity by Application
52. Customer landscape
54. Market share by geography 2019-2024 (%)
55. Geographic comparison
58. Europe - Market size and forecast 2019-2024 ($ billion)
60. Europe - Year-over-year growth 2019-2024 (%)
63. North America - Market size and forecast 2019-2024 ($ billion)
65. North America - Year-over-year growth 2019-2024 (%)
68. APAC - Market size and forecast 2019-2024 ($ billion)
70. APAC - Year-over-year growth 2019-2024 (%)
73. South America - Market size and forecast 2019-2024 ($ billion)
75. South America - Year-over-year growth 2019-2024 (%)
78. MEA - Market size and forecast 2019-2024 ($ billion)
80. MEA - Year-over-year growth 2019-2024 (%)
82. Key leading countries
84. Market opportunity by geography ($ billion)
85. Impact of drivers and challenges
86. Vendor landscape
88. Landscape disruption
90. Industry risks
92. Vendors covered
94. Market positioning of vendors
96. Anecova SA - Overview
97. Anecova SA - Product and service
98. Anecova SA - Key offerings
99. Anecova SA - Key customers
100. Anecova SA - Segment focus
102. CRITEX GmbH - Overview
103. CRITEX GmbH - Product and service
104. CRITEX GmbH - Key offerings
105. CRITEX GmbH - Key customers
106. CRITEX GmbH - Segment focus
108. Esco Micro Pte. Ltd - Overview
109. Esco Micro Pte. Ltd - Product and service
110. Esco Micro Pte. Ltd - Key offerings
111. Esco Micro Pte. Ltd - Key customers
112. Esco Micro Pte. Ltd - Segment focus
114. FUJIFILM Holdings Corp. - Overview
115. FUJIFILM Holdings Corp. - Business segments
116. FUJIFILM Holdings Corp. - Key offerings
117. FUJIFILM Holdings Corp. - Key customers
118. FUJIFILM Holdings Corp. - Segment focus
120. INVO Bioscience Inc - Overview
121. INVO Bioscience Inc - Product and service
122. INVO Bioscience Inc - Key offerings
123. INVO Bioscience Inc - Key customers
124. INVO Bioscience Inc - Segment focus
126. Merck KGaA - Overview
127. Merck KGaA - Business segments
128. Merck KGaA - Key offerings
129. Merck KGaA - Key customers
130. Merck KGaA - Segment focus
132. Monash IVF Group Ltd. - Overview
133. Monash IVF Group Ltd. - Business segments
134. Monash IVF Group Ltd. - Key offerings
135. Monash IVF Group Ltd. - Key customers
136. Monash IVF Group Ltd. - Segment focus
138. The Cooper Companies Inc. - Overview
139. The Cooper Companies Inc. - Business segments
140. The Cooper Companies Inc. - Key offerings
141. The Cooper Companies Inc. - Key customers
142. The Cooper Companies Inc. - Segment focus
144. Virtus Health Ltd. - Overview
145. Virtus Health Ltd. - Business segments
146. Virtus Health Ltd. - Key offerings
147. Virtus Health Ltd. - Key customers
148. Virtus Health Ltd. - Segment focus
150. Vitrolife AB - Overview
151. Vitrolife AB - Business segments
152. Vitrolife AB - Key offerings
153. Vitrolife AB - Key customers
154. Vitrolife AB - Segment focus
156. Currency conversion rates for US$
157. Research Methodology
158. Validation techniques employed for market sizing
159. Information sources
160. List of abbreviations
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Anecova SA
- CRITEX GmbH
- Esco Micro Pte. Ltd
- FUJIFILM Holdings Corp.
- INVO Bioscience Inc
- Merck KGaA
The publisher recognizes the following companies as the key players in the global assisted reproductive technology market 2020-2024: Anecova SA, CRITEX GmbH, Esco Micro Pte. Ltd, FUJIFILM Holdings Corp., INVO Bioscience Inc, Merck KGaA, Monash IVF Group Ltd., The Cooper Companies Inc., Virtus Health Ltd. and Vitrolife AB.
Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the increase in awareness of art."
According to the report, one of the major drivers for this market is the increase in rate of infertility and obesity related cases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the increase in awareness of art."
According to the report, one of the major drivers for this market is the increase in rate of infertility and obesity related cases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
- Anecova SA
- CRITEX GmbH
- Esco Micro Pte. Ltd
- FUJIFILM Holdings Corp.
- INVO Bioscience Inc
- Merck KGaA
- Monash IVF Group Ltd.
- The Cooper Companies Inc.
- Virtus Health Ltd.
- Vitrolife AB
Note: Product cover images may vary from those shown
LOADING...
